Enable Block: 

The US Food and Drug Administration (FDA) has approved diabetes drug Liraglutide (Saxenda, Novo Nordisk) for the treatment of obesity.

Case in the United States Court of Appeals regarding approval for use of penicillin and tetracyclines in animal feed, 24/07/2014.

Read More: Appeals court decision on NRDC’s lawsuit against FDA for failing to address antibiotic overuse in livestock production